COMPANY NAME	REVENUES 12 Months Ending Q1 2024	MARKET SHARE 12 Months Q1 2024	MARKET SHARE MRQ Q1 2024	MARKET SHARE A Quarter Before Q4 2023
Renalytix Plc	2.35	0.02%	0.01 %	0.02 %
Davita Inc	14,009.65	99.92%	99.93%	99.93%
Digital Brands Group Inc	5.72	0.04%	0.03%	0.03%
Adm Tronics Unlimited Inc	3.24	0.02%	0.02%	0.02%

RNLX's Market share relative to its competitors, as of Q1 2024 within the Healthcare Sector

As of Q1 2024

COMPANY NAME	MARKET SHARE 12 Months Ending Q1 2024	MARKET SHARE 12 Months Ending Q4 2023	MARKET SHARE MRQ Q1 2024	MARKET SHARE Q4 2023
Renalytix Plc	0.02%	0.02%	0.01 %	0.02 %
Davita Inc	99.96%	99.96%	99.96%	99.96%
Adm Tronics Unlimited Inc	0.02%	0.02%	0.02%	0.02%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Renalytix Plc's market divisions, geographic dispersion, segments, products, and services, visit Renalytix Plc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.